Fresenius Kabi USA, LLC recalls 5% Dextrose Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility
- Products
-
- 5% Dextrose Injection
- Company
- Fresenius Kabi USA, LLC
- Where it was sold
-
US Nationwide , Alaska, and Puerto Rico.
Nationwide
- About this recall
- 5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-458-05, Unit of Sale NDC Number: 65219-458-30.